Atrial Fibrillation—European and Swiss Perspectives: Reflections on Epidemiology, Costs and Treatment Options
Abstract
Epidemiology
Impact on morbidity and mortality
Costs of atrial fibrillation
Treatment options
Use of pulmonary vein isolation in Switzerland and other European countries
Conclusions
Funding/potential competing interests
References
- Camm, A.J.; Kirchhof, P.; Lip, G.Y.H.; Schotten, U.; et al.; European Heart Rhythm Association European Association for CardioThoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010, 12, 1360–1420. [Google Scholar] [PubMed]
- Kannel, W.B.; Abbott, R.D.; Savage, D.D.; McNamara, P.M. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982, 306, 1018–1022. [Google Scholar] [CrossRef] [PubMed]
- DeWilde, S.; Carey, I.M.; Emmas, C.; Richards, N.; Cook, D.G. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006, 92, 1064–1070. [Google Scholar] [CrossRef]
- Andersson, T.; Magnuson, A.; Bryngelsson, I.L.; Frøbert, O.; Henriksson, K.M.; Edvardsson, N.; et al. All cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long term case control study. Eur Heart J. 2013, 34, 1061–1067. [Google Scholar] [CrossRef]
- Heeringa, J.; van der Kuip, D.A.M.; Hofman, A.; Kors, J.A.; van Herpen, G.; Stricker, B.H.C.; et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006, 27, 949–953. [Google Scholar] [CrossRef]
- Rietbrock, S.; Heeley, E.; Plumb, J.; van Staa, T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J. 2008, 156, 57–64. [Google Scholar] [CrossRef] [PubMed]
- Kirchhof, P.; Lip, G.Y.H.; Van Gelder, I.C.; Bax, J.; Hylek, E.; Kaab, S.; et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options – a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012, 14, 8–27. [Google Scholar] [CrossRef]
- Benjamin, E.J.; Wolf, P.A.; D’Agostino, R.B.; Silbershatz, H.; Kannel, W.B.; Levy, D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98, 946–952. [Google Scholar] [CrossRef]
- Stewart, S.; Hart, C.L.; Hole, D.J.; McMurray, J.J.V. A population based study of the long term risks associated with atrial fibrillation: 20 year followup of the Renfrew/Paisley study. Am J Med. 2002, 113, 359–364. [Google Scholar] [CrossRef]
- Stewart, S.; Murphy, N.F.; Murphy, N.; Walker, A.; McGuire, A.; McMurray, J.J.V. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004, 90, 286–292. [Google Scholar] [CrossRef]
- Ringborg, A.; Nieuwlaat, R.; Lindgren, P.; Jönsson, B.; Fidan, D.; Maggioni, A.P.; et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 2008, 10, 403–411. [Google Scholar] [CrossRef]
- Wu, E.Q.; Birnbaum, H.G.; Mareva, M.; Tuttle, E.; Castor, A.R.; Jackman, W.; et al. Economic burden and co morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005, 21, 1693–1699. [Google Scholar] [CrossRef] [PubMed]
- Hylek, E.M.; Go, A.S.; Chang, Y.; Jensvold, N.G.; Henault, L.E.; Selby, J.V.; et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003, 349, 1019–1026. [Google Scholar] [PubMed]
- Corley, S.D.; Epstein, A.E.; DiMarco, J.P.; Domanski, M.J.; Geller, N.; Greene, H.L.; et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109, 1509–1513. [Google Scholar] [CrossRef] [PubMed]
- Wyse, D.G.; Waldo, A.L.; DiMarco, J.P.; Domanski, M.J.; Rosenberg, Y.; Schron, E.B.; et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347, 1825–1833. [Google Scholar]
- Cappato, R.; Calkins, H.; Chen, S. .A.; Davies, W.; Iesaka, Y.; Kalman, J.; et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010, 3, 32–38. [Google Scholar] [CrossRef]
- Wazni, O.M.; Marrouche, N.F.; Martin, D.O.; Verma, A.; Bhargava, M.; Saliba, W.; et al. Radiofrequency ablation vs antiarrhythmic drugs as first line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005, 293, 2634–2640. [Google Scholar]
- Wilber, D.J.; Pappone, C.; Neuzil, P.; De Paola, A.; Marchlinski, F.; Natale, A.; et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010, 303, 333–340. [Google Scholar] [CrossRef]
- Jaïs, P.; Cauchemez, B.; Macle, L.; Daoud, E.; Khairy, P.; Subbiah, R.; et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008, 118, 2498–2505. [Google Scholar]
- Neumann, T.; Vogt, J.; Schumacher, B.; Dorszewski, A.; Kuniss, M.; Neuser, H.; et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3 center study. J Am Coll Cardiol. 2008, 52, 273–278. [Google Scholar] [CrossRef]
- Boersma, L.V.A.; Wijffels, M.C.E.F.; Oral, H.; Wever, E.F.D.; Morady, F. Pulmonary vein isolation by duty cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm. 2008, 5, 1635–1642. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, B.; Antz, M.; Ernst, S.; Ouyang, F.; Falk, P.; Chun, J.K.R.; et al. Pulmonary vein isolation by high intensity focused ultrasound: first in man study with a steerable balloon catheter. Heart Rhythm. 2007, 4, 575–584. [Google Scholar] [CrossRef]
- Arribas, F.; Auricchio, A.; Wolpert, C.; Merkely, B.; Merino, J.L.; Boriani, G.; et al. The EHRA White Book. Europace 2012, 14 (suppl 3), ii1–ii55. [Google Scholar] [CrossRef]
- Camm, A.J.; Lip, G.Y.H.; De Caterina, R.; Savelieva, I.; Atar, D.; Hohnloser, S.H.; et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012, 33, 2719–2747. [Google Scholar]
- Santangeli, P.; Di Biase, L.; Pelargonio, G.; Dello Russo, A.; Casella, M.; Sanchez, J.; et al. Catheter ablation of atrial fibrillation: randomized controlled trials and registries, a look back and the view forward. J Interv Card Electrophysiol. 2011, 31, 69–80. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2014 by the author. Attribution-Non-Commercial-NoDerivatives 4.0.
Share and Cite
Pavlovic, N.; Sticherling, C.; Kühne, M. Atrial Fibrillation—European and Swiss Perspectives: Reflections on Epidemiology, Costs and Treatment Options. Cardiovasc. Med. 2014, 17, 167. https://doi.org/10.4414/cvm.2014.00242
Pavlovic N, Sticherling C, Kühne M. Atrial Fibrillation—European and Swiss Perspectives: Reflections on Epidemiology, Costs and Treatment Options. Cardiovascular Medicine. 2014; 17(6):167. https://doi.org/10.4414/cvm.2014.00242
Chicago/Turabian StylePavlovic, Nikola, Christian Sticherling, and Michael Kühne. 2014. "Atrial Fibrillation—European and Swiss Perspectives: Reflections on Epidemiology, Costs and Treatment Options" Cardiovascular Medicine 17, no. 6: 167. https://doi.org/10.4414/cvm.2014.00242
APA StylePavlovic, N., Sticherling, C., & Kühne, M. (2014). Atrial Fibrillation—European and Swiss Perspectives: Reflections on Epidemiology, Costs and Treatment Options. Cardiovascular Medicine, 17(6), 167. https://doi.org/10.4414/cvm.2014.00242